**—I would fix the artifact and several manuscript inconsistencies before submitting.** The paper meets the basic format requirements, but the ZIP fails its documented reproduction procedure.

I reviewed all 10 rendered pages of paper/latex/ichi\_latex.pdf and inspected and tested release/reproducibility\_artifact.zip.

**What passes**

- **Length and format:** 10 pages total, more than six pages before references, IEEE conference layout, embedded fonts. These meet the published [early-submission requirements](<https://ichi2027.github.io/ICHI2027/call-for-early-submission.html>).
- **Presentation:** Figures and tables render without obvious clipping or overlap. Page 9 has substantial unused space.
- **Consistency:** All **1,044 checksums pass**; packaged tables and v4 number macros match the paper’s source. The first statistics stage independently reproduces its expected JSON exactly.
- **Anonymity:** No author names or affiliations on the manuscript, and no obvious identifying PDF metadata.

**Fix before submitting**

| Priority | Finding | Required action |
|---|---|---|
| **High** | Following the README in a clean Python 3.12 environment, `reproduce.sh` fails with **`ModuleNotFoundError: No module named 'fsspec'`**. The import chain also requires undocumented `nibabel` and `requests`. | Correct the dependencies or remove unnecessary imports, then rerun the entire workflow in a clean environment. |
| **High** | The paper claims code regenerates every statistic, but alternative-assignment robustness results are provided as summaries; their underlying `results/robustness/` response folders are absent. | Include those responses and working regeneration commands, or narrow the reproducibility claim explicitly. |
| **High** | The manuscript says “preregistered,” but the ZIP omits the analysis plan/change log. The local plan explicitly says it was **not externally timestamped** and documents a rebuild from 62 to 46 patients after initial runs. | Include an anonymized plan and amendments; describe it accurately as an internal prespecified analysis plan and disclose the rebuild. |
| **Medium** | Figure 1 specifies sampling **seed 42**, while the packaged selection report and implementation use **20260925**. | Correct the figure. |
| **Medium** | Pages 5–6 direct readers to **Table IV / Appendix A** for bf16 controls, but Table IV contains only Gemini results. | Add the control results or point to their precise supplementary location. |
| **Low** | The title page still says **“Paper ID: (assigned at submission)”**. | Remove the placeholder or replace it if the submission system requires an ID. |

**The main scientific review risk remains label validity.** Your limitations acknowledge that clinicians have not verified the items, and that the automated enhancement rule omits parts of clinical RANO assessment. That transparency helps. However, **38% agreement establishes disagreement between labeling procedures; it does not establish that expert ratings are unsuitable for the displayed slices.** I would soften that inference in the abstract, introduction, and conclusion, and keep the contribution centered on the evaluation protocol.



No submission files were changed.

- Repair the artifact
- Correct the manuscript
- Tighten the scientific claims